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During embryonic development, multipotent endodermal cells differentiate to form the
pancreas. Islet cell clusters arising from the pancreatic bud form the acini tissue
and exocrine ducts whilst pancreatic islets form around the edges of the clusters.
The successive steps of islet differentiation are controlled by a complex network of
transcription factors and signals that influence cell differentiation, growth and lineage.
A Westernized lifestyle has led to an increased consumption of a high saturated fat
diet, and an increase in maternal obesity. The developing fetus is highly sensitive to the
intrauterine environment, therefore any alteration in maternal nutrition during gestation
and lactation which affects the in-utero environment during the key developmental phases
of the pancreas may change the factors controlling β-cell development and β-cell mass.
Whilst the molecular mechanisms behind the adaptive programming of β-cells are still
poorly understood it is established that changes arising from maternal obesity and/or
over-nutrition may affect the ability to maintain fetal β-cell mass resulting in an increased
risk of type 2 diabetes in adulthood.
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INTRODUCTION
The pancreas is composed of both exocrine and endocrine tis-
sue. The exocrine gland secretes digestive enzymes while the
endocrine gland, which consists of the islets of Langerhans,
secretes hormones into the bloodstream. Each individual islet
is composed of a number of endocrine cells specializing in the
secretion of specific hormones (Bonner-Weir and Orci, 1982).
There are four main endocrine cells contained within an islet:
insulin producing β-cells; α-cells, which produce glucagon; δ-
cells, which produce somatostatin and PP-cells, which secrete
pancreatic polypeptide.
The development of the pancreas is a complex process. During
embryogenesis the pancreas is derived from the gut and a cascade
of signaling processes acts on precursor cells to determine their
cell fate generating both exocrine and endocrine cells prior to
birth. In rodents, β-cell neogenesis, the generation of new β-cells
(Paris et al., 2004) continues throughout neonatal life, but ceases
shortly after weaning (Deltour et al., 1991). Any environmental
stress or stimulus during these critical periods of early develop-
ment can permanently alter endocrine mass and β-cell function
resulting in long-term health consequences in the developing
infant (McMillen and Robinson, 2005).
Over recent decades there has been a rapid rise in metabolic
disorders throughout the world. A Westernized lifestyle and soci-
etal habits have contributed to the obesity and type 2 diabetes
epidemics. TheWHO estimates that in 2008 there were more than
1.4 billion overweight adults worldwide, 500 million of which
Abbreviations: Rodent gene symbols are italicized, with only the first letter in
uppercase and the remaining letters in lowercase while rodent protein symbols are
not italicized and all are upper case. Human gene symbols are italicized, with all
letters in uppercase.
are obese (WHO, 2013). As the number of obese individuals
increase, and in particular in women of child-bearing age, so does
the rate of obese pregnancies. There is now increasing evidence
that the early developmental environment of an infant can play
a pivotal role in the “programming” of an adverse physiological
phenotype in later life. Clinical evidence highlights that maternal
over-nutrition and/or obesity presents not only adverse effects on
maternal health, but also persistent and deleterious effects in the
developing child (Nelson et al., 2010; Alfaradhi andOzanne, 2011;
Poston, 2012; Rkhzay-Jaf et al., 2012) (Figure 1).
In clinical studies it is harder to dissect out the effects of
maternal obesity from those of an obesogenic diet, however,
this can be addressed in animal models. Animal models pro-
vide essential insight into the underlying cellular and molecu-
lar mechanisms that contribute to this adverse phenotype. The
majority of research has focused on sheep and rodents (Li
et al., 2011). While many developmental events occur postna-
tally in rodents, the short gestation period, development of the
metabolic syndrome within months, cost effectiveness and lon-
gitudinal nature of these studies, means that rodents are the
most commonly used models (Alfaradhi and Ozanne, 2011).
Sheep and non-human primates do offer advantages because
of the similarities of their developmental patterns to humans;
however, long gestation periods and high costs make them
less available. The information gained from these animal stud-
ies not only aids our understanding of the programming sig-
nals related to maternal and paternal over-nutrition but may
enable the improved healthcare for both mother and infant.
This review will firstly describe the development of the pan-
creatic β-cell and will then examine the impact of develop-
mental programming as a result of maternal over-nutrition on
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FIGURE 1 | Common mechanistic pathways of developmental programming as a result of maternal over-nutrition and obesity.
these underlying mechanisms and the resulting phenotype of the
offspring.
DEVELOPMENT OF THE ENDOCRINE PANCREAS
EMBRYONIC DEVELOPMENT OF THE PANCREAS
Gastrulation is a key stage in early embryonic development.
Inward migration of cells at or near the surface of the embryo
reorganizes the single layered blastula into a three layered struc-
ture composed of the ectoderm, mesoderm and endoderm germ
layers. Each layer gives rise to specific tissues and organs in
the developing embryo. The pancreas and other gastrointestinal
organs are derived from the endoderm.
The pancreas is formed in the uterus from the fusion of two
separate pancreatic ducts, the dorsal and ventral. The dorsal pan-
creatic bud first appears at approximately embryonic day 9.5
(E9.5) in the mouse (Figure 2) [day 25 of gestation in humans
(Piper et al., 2002)], as a diverticulum from the dorsal aspect
in the primitive gut endoderm, in the area that will become
the duodenum, a short distance above the hepatic diverticulum
(Wessells and Cohen, 1967). Shortly after, the ventral pancreatic
bud appears as a diverticulum from the primitive bile duct. By
E11.5 in the mouse the two buds grow rapidly sending finger-like
epithelial protrusions into the surrounding mesenchyme leading
to the formation of highly branched structures (Zhou et al., 2007;
Figure 2).
The dorsal duct grows upward and backward into the dorsal
mesogastrium, forms a part of the head and uncinate process
and the whole of the body and tail of the pancreas; while the
ventral duct forms the remainder of the head and uncinate pro-
cess of the pancreas (Gittes, 2009). The dorsal duct drains the
major portion of the embryonic pancreas into the duodenum and
the ventral duct drains only a small part into the common bile
duct. By embryonic day 16–17 (E16–17) in the mouse the ventral
pancreatic bud and the dorsal pancreatic bud fuse and estab-
lish communication between the two ducts (Pictet and Rutter,
1972; Sander and German, 1997). At this time the region between
the duodenum and the point of fusion undergoes little, or no,
enlargement while the pancreatic duct increases in size and forms
a highly branched structure that forms the adult pancreatic duct
(Jorgensen et al., 2007).
All islet cell types are believed to be derived from one com-
mon progenitor cell (Yamaoka and Itakura, 1999) located at the
tips of the branching structures (Zhou et al., 2007). In the mouse,
endocrine cells are formed continuously from E9.5 until birth,
with a major burst in β-cell generation between E13.5 and E16.5
(Ahnfelt-Ronne et al., 2012). Before distinct cell types form,
insulin and glucagon, pancreatic polypeptide and amylase mRNA
are expressed at embryonic days E9.5, E10.5, and E12.5 respec-
tively (Herrera et al., 1991; Gittes and Rutter, 1992; Deltour et al.,
1993). Acini and ductal cells become apparent as histologically
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FIGURE 2 | Organogenesis of the murine pancreas. The pancreatic
bud begins around day 9 of gestation (E9.5) in the mouse embryo.
At E11.5 the pancreatic ductal epithelium grows and branches into the
surrounding mesenchyme. The epithelial cells differentiate into exocrine
and endocrine cells at E15.5. Ductal, acinar, and islet cells are clearly
found by E18.5.
distinct structures as early as E15.5 in the mouse; while the islets
of Langerhans do not form until around E18.5 (Herrera et al.,
1991; Figure 2). After this time, endocrine cell numbers increase
rapidly, as a result of ductal epithelial neogenesis rather than
multiplication of precursor cells (Deltour et al., 1991; Kaung,
1994). The dorsal primordium is rich in glucagon-containing cells
and the ventral primordium is rich in pancreatic polypeptide-
containing cells (Malaisse-Lagae et al., 1979; Stefan et al., 1982)
the dorsal lobe, derived from the dorsal duct, possess islets with
a β-cell core surrounded by α- and δ-cells, while the ventral lobe
islets have a mantle of PP and δ-cells surrounding the β-cell core
(Tasaka et al., 1989). In the human fetus, endocrine cells begin
to bud from the pancreatic duct at around week 10 of gestation.
The functional endocrine pancreas continues to develop through-
out pregnancy followed by a phase of islet remodeling from late
gestation onwards for at least 4 years (Fowden and Hill, 2001;
McMillen and Robinson, 2005). Hence, irrespective of species,
throughout the process of embryogenesis not all pancreatic islets
have the same endocrine cell content.
TRANSCRIPTION FACTORS CONTROLING PANCREATIC DEVELOPMENT
The embryological development of the pancreas and the
endocrine and exocrine cells is tightly controlled. Throughout
these stages of development a network of transcription factors
regulate genes that direct cellular differentiation and cell fate
(Figure 3). While some transcription factors are only required at
specific stages of the formation of the islet cell others are required
in multiple stages of endocrine cell development (Murtaugh,
2007).
Transcription factors
Pdx-1. Pancreatic duodenal homeobox 1 (Pdx-1) is one of the
first transcription factors expressed, with gene expression start-
ing as early as E8.5 in the mouse in the foregut endoderm
(Offield et al., 1996). All the cells derived from the endoderm
have been shown to express Pdx-1 (Gu et al., 2002). Both the
ventral and dorsal pancreatic buds express Pdx-1 at E9.5 (Offield
et al., 1996). At approximately E10 expression of Pdx-1 mRNA is
then downregulated with expression becoming restricted only to
endocrine cells in the pancreas and this is maintained in adult
β-cells (Ohlsson et al., 1993; Ahlgren et al., 1998). Pdx-1 itself
is an essential mediator of mesenchymal signaling, necessary for
the branching morphogenesis involved in ductal network forma-
tion of the pancreas at E10.5 (Ahlgren et al., 1996). Germline
knockout studies have shown that while knockdown of Pdx-1
prior to E10.5 has no effect on pancreatic developmental pro-
cesses (Wescott et al., 2009), the targeted pancreatic deletion at
E10.5 or later results in pancreatic agenesis (Ahlgren et al., 1996;
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FIGURE 3 | Pancreatic cell lineage and the role of transcription factors
during islet cell type development. All mature pancreatic cell types are
derived from progenitors that express Pdx-1 and/or Ptf1a. Mnx-1 and Mib-1
act to regulate notch ligand activity. Ngn3 expression in pancreatic progenitor
cells gives rise to ductal, acini, and endocrine progenitor cells. Nkx2.2 and
Nkx6.1 work alongside other transcription factors including PDX-1, MafA
Mnx1, Isl1 and NeuroD1 to regulate the formation of the majority of islet
β-cells.
Offield et al., 1996). Pdx-1 contains three principal transcription
initiation sites (Sharma et al., 1996) and in the β-cell each of these
sites may be activated by the binding of a specific set of tran-
scription factors (Melloul et al., 2002); FOXA2, HNF6, PTF1a,
MNX-1, MAFA, HNF, SP1/3, USF1/2 and PDX-1 itself (Harrison
et al., 1999; Melloul et al., 2002; Jacquemin et al., 2003; Gao et al.,
2008; Vanhoose et al., 2008).
Interestingly, reduced expression of the PDX-1 gene within the
human pancreas has been linked with type 2 diabetes, a rare auto-
somal dominant form of type 2 diabetes called maturity onset
diabetes of the young (MODY4) and pancreatic agenesis (Lin and
Vuguin, 2012).
Ptf1a/p48. Ptf1a (pancreas specific transcription factor 1a/p48) is
a basic helix-loop-helix (bHLH) transcription factor (Beres et al.,
2006). It was first identified as a subunit of the trimeric PTF1
transcription factor complex, and has been found to be crucial
for the regulation of exocrine gene transcription (Ohlsson et al.,
1993; Krapp et al., 1996). Endodermal expression of Ptf1a/p48
is pancreas specific throughout development; being expressed
in endocrine, exocrine and ductal cell types (Kawaguchi et al.,
2002). PTF1a protein has been detected as early as E8–8.75 in
the ventral and dorsal pancreatic ducts (Hald et al., 2008) but
by E13.5 expression becomes restricted to acinar precursor cells
(Kawaguchi et al., 2002). In adult rodents, PTF1a/p48 transcrip-
tion factor protein is expressed in acinar tissue and induces
amylase and elastase gene expression.
While a deficiency in PTF1a/p48 protein does not inhibit the
initial formation of the pancreas it does cause a complete lack
of acinar cell development (Krapp et al., 1998; Kawaguchi et al.,
2002). Cell lineage studies have shown that this is through cells
adopting an intestinal fate rather than becoming cells within the
ventral pancreas (Kawaguchi et al., 2002). Defects in the human
PTF1a protein are associated with permanent neonatal diabetes
mellitus (Masui et al., 2007). It has recently been suggested that
Ptf1a-mediated control of Delta-like ligand 1 (Dll1) expression
is crucial for Notch-mediated control of early pancreas devel-
opment (Ahnfelt-Ronne et al., 2012). The Ptf1a activation of
Dll1 within multipotent progenitor cells (MPC) stimulates pro-
liferation and pancreas growth by maintenance of HES1 (hairy
and enhancer of split 1) expression and PTF1a protein levels
(Ahnfelt-Ronne et al., 2012).
Endocrine lineage specification
Differentiation of the cells into each endocrine cell type found
within the islet of Langerhans begins at specific time points dur-
ing embryogenesis. For α-cells this is E9.5, for β-cells E10.5, for
δ-cells at E14.5 and lastly PP cells at E18.5. The critical window
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of differentiation of endocrine cells in humans is from weeks 7 to
23 of gestation (Lin and Vuguin, 2012). Glucagon-producing α-
cells are found at week 7, followed by insulin-producing β-cells,
somatostatin-producing δ-cells and pancreatic polypeptide PP
cells at weeks 8–10 gestation (Lin and Vuguin, 2012). Importantly,
the processes that control the development of each cell type are
governed by a complex signaling cascade.
Notch cell signaling. The notch cell signaling pathway is a well-
conserved signaling pathway that regulates cell fate determination
during embryonic development as well as the maintenance of
tissue homeostasis during adult life (Bigas and Espinosa, 2012).
During development Notch signaling must be regulated to bal-
ance the expansion of the progenitor pool with the differentiation
of mature cell types (Greenwood et al., 2007), with genetic per-
turbations of this pathway resulting in a change in pancreatic cell
fate (Apelqvist et al., 1999). Notch-mediated signaling ensures
the appropriate maintenance of the progenitor cell population
through the activation of the bHLH factor Hes1 (Jensen et al.,
2000). Loss-of-function experiments have shown that Notch sig-
naling promotes pancreatic progenitor cell self-renewal and/or
exocrine lineage commitment (Murtaugh et al., 2003). A reduc-
tion in Notch signaling increases the expression of the pro-
endocrine gene Ngn3, promoting an endocrine fate; while those
cells exposed to Notch signaling express Hes-1 and p48 mRNA
and adopt an exocrine fate (Apelqvist et al., 1999).
Ngn3. Neurogenin 3 (NGN3) is one of the most important tran-
scription factors for endocrine development. All endocrine cell
types are derived from progenitor cells expressing the Ngn3 gene
(Gu et al., 2002). The bHLH transcription factor is expressed in
two distinct waves (Villasenor et al., 2008). The first phase ofNgn3
expression begins in murine pancreatic progenitor cells at E8.5–
9 resulting in glucagon producing cells, while the second begins
at E12 with expression peaking at E15.5 corresponding with
endocrine cell differentiation (Gradwohl et al., 2000; Schwitzgebel
et al., 2000). Ngn3 null animals are born without islets, and lack
all endocrine cell types, develop type 1 diabetes and die 1–3 days
after birth (Gradwohl et al., 2000). Ngn3 has been associated
with several downstream factors involved in endocrine differen-
tiation and cell subtype specification and maintenance, including
Nkx2.2, Nkx6.1, Pax4 Isl1, b2/NeuroD1, Pax6 and Pdx-1 (Huang
et al., 2000; Smith et al., 2003; Collombat et al., 2005).
Pax4—Arx. The paired box containing gene 4 (Pax4) mRNA is
first detected at E9.5 and is transiently expressed in all endocrine
progenitors during pancreatic development, being downregulated
shortly after birth (Lin and Vuguin, 2012). Pax4 is expressed
downstream of Ngn3, with expression being lost in Ngn3 null
mice but not vice versa (Gradwohl et al., 2000; Wang et al., 2004).
Pax4 activity appears essential for the appropriate initiation of
β-cell differentiation (Collombat et al., 2005). In the absence of
Pax4, β- and δ- cells fail to develop andmore α- cells are observed
(Collombat et al., 2003, 2005; Sosa-Pineda, 2004). The loss of
Pax4 prevents the expression of Pdx-1, HB9 and insulin mRNA
in β-cell precursors (Wang et al., 2004). PAX4 has an oppos-
ing action to the transcription factor aristaless-related homeobox
gene (ARX) (Collombat et al., 2003). Arx gene expression begins
at E9.5 during mouse pancreatic development and persists into
mature α-cells (Collombat et al., 2003). Arx null mice lack α-cells
despite having no changes in total islet cell number (Collombat
et al., 2005). Therefore, it is the balance of Pax4 and Arx that is
crucial for cell fate determination of both α- and β- cells within
the islet (Collombat et al., 2005).
Nkx. Members of the NK homeodomain transcription factor
family are critical regulators of organ development (Stanfel et al.,
2005). Of these, Nkx2.2 andNkx6.1 are involved in endocrine cell
lineage and are likely to be the most important during pancreatic
development.
Nkx2.2. NKX2.2 is able to bind to both the insulin and Pax4 pro-
moters (Cissell et al., 2003). The Nkx2.2 gene is initially dorsally
expressed with Pdx-1 at E8.75 and ventrally at E9.5 (Jorgensen
et al., 2007). However, by E15.5 its expression becomes restricted
to only endocrine cells (Sussel et al., 1998). Nkx2.2 deficiency
results in a reduction of α- and PP-cells, and the complete loss
of β-cells (Sussel et al., 1998) and in the absence of Nkx2.2, β-cells
fail to activate insulin gene transcription and lack Nkx6.1, sug-
gesting that Nkx2.2 is essential for the specification of the mature
β-cell phenotype (Sussel et al., 1998).
Nkx6.1. Nkx6.1 pancreatic gene expression is similar to that of
Nkx2.2. In mouse models Nkx6.1 is expressed in the prospec-
tive ventral pancreas domain at E8.75. By E9.0 Nkx6.1 expression
switches from the ventral domain to the dorsal domain until
E10.5, when ventral expression of Nkx6.1 reappears (Jorgensen
et al., 2007) and then by E11.5, its expression becomes restricted
to the central epithelium (Jorgensen et al., 2007). In adult murine
islets,Nkx6.1 expression is restricted to β-cells (Jensen et al., 1996)
where it suppresses glucagon expression and modulates glucose
stimulated insulin secretion (Schisler et al., 2005). Nkx6.1 acts
downstream of Nkx2.2 (Sussel et al., 1998) Not only do Nkx2.2
single mutant animals lack expression of Nkx6.1 within the β-cell
(Sussel et al., 1998) but theNkx6.1 promoter contains a conserved
binding site for Nkx2.2 (Sander et al., 2000). In fact, Nkx6.1 defi-
ciency does not affect early pancreas development, but it does
result in compromised β-cell development (Sander et al., 2000)
and mutant animals lacking both Nkx2.2/Nkx6.1 have a pheno-
type identical to that of Nkx2.2 knockout animals (Sander et al.,
2000).
Maintenance of β-cell identity
NeuroD1/Beta2. NeuroD1/Beta2, a bHLH, is first expressed in
mouse pancreatic cells from E9.5 (Naya et al., 1997). By E12.5,
NeuroD1/Beta2 mRNA is found in both dorsal and ventral
pancreatic buds and from E17.5 gene and protein expression
is restricted to small clusters of endocrine cells and is rarely
detected in ductal epithelial cells (Chu et al., 2001). In adult
islets, NeuroD1/Beta2 is expressed in all endocrine cells of the
islet, although its function still remains unknown. While it is
believed that NeuroD1/Beta2 plays a role in regulating insulin
(Sharma et al., 1999) and glucagon mRNA expression, mice lack-
ingNeuroD1/Beta2 are still able to produce functional insulin and
glucagon (Chu et al., 2001).
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Large Maf transcription factors. The Maf family of transcrip-
tion factors belong to the basic leucine-zipper (bZIP) family that
have been associated with the regulation of a number of differ-
entiation processes (Hang and Stein, 2011). The Maf family is
divided into two groups (small and large) based on their molec-
ular size (Hang and Stein, 2011). The large Maf proteins MAFA,
MAFB, c-MAF and NRL contain a transactivation domain in the
N-terminal region and are key regulators of cellular differentia-
tion (Yang and Cvekl, 2007; Hang and Stein, 2011). In adult islets,
MAFA, MAFB, and c-MAF are expressed unlike NRL (Matsuoka
et al., 2003), supporting a role for NRL in islet cell development.
MafA. MafA gene expression starts at E13.5 and continues
throughout adulthood in the mouse (Matsuoka et al., 2003).
MafA knockout mice display no changes in pancreas develop-
ment, but the mice do go on to develop glucose intolerance and
type 2 diabetes as a result of reduced β-cell mass and increased
β-cell apoptosis (Zhang et al., 2005). Furthermore, MAFA binds
to the insulin promoter and through its interaction with PDX-1
andNEUROD1, activates insulin gene transcription (Olbrot et al.,
2002; Aramata et al., 2005).
MafB. In the adult mouse pancreas MafB is expressed within the
islet α-cells where it regulates glucagon gene expression (Artner
et al., 2006, 2007). Expression of MafB mRNA within the mouse
pancreas begins as early as E10.5 in glucagon-positive cells,
before expression in islet positive cells at E12.5 (Artner et al.,
2006). MafB becomes progressively restricted to α-cells postna-
tally through the downregulation of its expression in β-cells in
the first 2 weeks after birth and its expression is undetectable in
these cells 3 weeks after birth (Artner et al., 2007). MAFB plays
a pivotal role in the development and differentiation of α- and
β-cells during pancreatogenesis by directly affecting the transcrip-
tion of specific genes present in α- or β- cells as opposed to genes
which are more ubiquitously expressed in other islet cell types
(e.g., Pax6, Isl1 andNeuroD1) (Artner et al., 2007).
Mib-1. Mind bomb 1 (Mib-1) encodes an E3 ubiquitin ligase
essential for Notch ligand activity (Itoh et al., 2003) that is
required for correct proximodistal patterning in the develop-
ing pancreas as well as in β-cell formation (Horn et al., 2012).
Endodermal-specific inactivation of Mib-1 causes the proximal
cells of the developing pancreas to adopt a distal fate resulting in
a reduction in β-cells (Horn et al., 2012).
Mnx-1. The homeodomain transcription factor MNX1 (HB9)
plays a key role in pancreatic development and function
(Harrison et al., 1999; Li et al., 1999; Dalgin and Prince, 2012).
Murine Mnx-1 gene expression begins at E8 (Lin and Vuguin,
2012). Work in zebrafish suggests thatMnx-1may suppress α- cell
fate in β-cell precursors (Dalgin and Prince, 2012). Furthermore,
Mnx-1 knockout mice fail to develop the dorsal lobe of the
pancreas with the remnant pancreas having smaller islets of
Langerhans with reduced β-cell numbers expressing low levels of
Glut2 andNkx6.1 (Harrison et al., 1999).
Lbl-11/Isl-1. The transcriptional regulator Islet-1 (Isl-1) gene is
expressed in the developing mouse pancreas at E8–8.5 (Lin and
Vuguin, 2012) but is later restricted only to the endocrine cells
of adult islets, where it is involved in the maturation, prolifera-
tion and survival of the second wave of islet cells (Du et al., 2009).
Isl-1 directly regulatesMafA, a potent regulator of the insulin gene
and β-cell function (Du et al., 2009). Isl-1 deficient animals fail to
develop functional β-cells, and have a reduced ability to expand
their endocrine cell mass postnatally and consequently become
diabetic (Du et al., 2009). A nonsense mutation of the ISL-1
gene has been found in a case of human type 1 diabetic patient.
Activation of Isl-1 is regulated in part by the transcriptional co-
regulator, LIM domain-binding protein 1 (LBL-1) (Hunter et al.,
2013).
Other factors
microRNAs. microRNAs (miRNAs) are small non-coding RNA
molecules (∼19–22 nt) that regulate gene expression by bind-
ing to complementary sequences in the 3′UTR regions of specific
mRNAs (Ambros, 2004). One of the first miRNAs to be iden-
tified in the β-cell was miR-375 (Poy et al., 2004). miR-375 is
regulated by several transcription factors involved in pancre-
atic development and function, including HNF6, INSM1, NGN3,
NEUROD1, and PDX-1 (Keller et al., 2007), with knockout stud-
ies showing that miR-375 is key to pancreatic development (Poy
et al., 2009). Since the identification of miR-375, a great number
more miRNAs have been implicated in many aspects of pan-
creatic development including regulating ductal, exocrine, and
endocrine development (Lynn et al., 2007). For example miR-18a
plays a role in regulating pancreatic progenitors and exocrine cells
through the repression of Ptf1a expression (Yang et al., 2012).
Cell cycle regulators. Regulators of the cell cycle have been rel-
atively understudied during pancreatic development; Of those
studied, p27 is a key regulator in establishing β-cell mass; during
embryogenesis accumulates in terminally differentiated β-cells
where it acts to maintain a quiescent state (Georgia and Bhushan,
2006). Inactivation of p27 during embryogenesis results in an
increase in β-cell mass at birth but interestingly does not affect the
postnatal expansion of β-cell mass (Georgia and Bhushan, 2006).
ISLET GROWTH AND DEVELOPMENT IN NEONATES
The neonatal period is divided into presuckling, suckling and
weaning phases. The presuckling period, which represents post-
natal days 1–2, describes the transition between fetal life, where
the placenta supplies most of the metabolic needs, and extra-
uterine life. During this period the islet adapts with alternating
feeding and fasting states whilst the total islet mass continues to
grow and in fact almost doubles during these 2 days (Freie et al.,
1975). Throughout postnatal days 3–14, the suckling period, β-
cell mass and insulin secretion adapt to the composition of the
maternal diet and to the dam’s feeding patterns. Following an ini-
tial reduction in growth and proliferation for all islet cell types
during postnatal days 3–4, during the suckling phase there is
rapid growth from days 4–10 (Kaung, 1994). During this phase
the rate of islet neogenesis is higher than the rate of islet growth,
resulting in a large number of small islets (Ferrand et al., 1995).
Throughout the mid-stages of the suckling phase there is an
increase in the concentration of a number of pancreatic hor-
mones, followed by decrease from the end of the suckling through
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to weaning. Pancreatic insulin levels are at their highest between
postnatal days 7–21 and the levels of glucagon and somatostatin
increase considerably from birth reaching a peak between days 4
and 7 (Portha et al., 1974). During the weaning phase, postnatal
days 15–22, the whole system is honed to produce a fully devel-
oped pancreas. At this time, pancreatic weight doubles every 5–6
days until the end of the weaning phase and subsequently the islet
density is reduced (Freie et al., 1975).
ISLET GROWTH AND DEVELOPMENT IN THE ADULT
There are three main mechanisms involved in the regulation of
β-cell mass in adulthood: i) β-cell replication, which leads to an
expansion in β-cell number (hyperplasia), ii) β-cell hypertrophy,
which leads to an expansion in individual volume and differentia-
tion and iii) β-cell apoptosis. These processes and the underlying
mechanisms have been extensively reviewed previously (Bonner-
Weir, 2000). Despite no evidence of spontaneous neogenesis
occurring in the adult pancreas, it has now been shown that the
neogenesis of islets from ductal cells can be activated by exposure
to certain peptides (Bonner-Weir, 2000).
THE EFFECTS OF MATERNAL OBESITY AND A HIGH FAT DIET
ON OFFSPRING PANCREATIC DEVELOPMENT
The developmental programming hypothesis suggests that con-
ditions during key periods of fetal and early neonatal life may
impair pancreatic β-cell development and alter health in adult-
hood (Zambrano et al., 2006). It is well-established in rodent
models that intrauterine growth restriction (IUGR), followed
by normal or supranormal nutrition after birth can result in
impaired growth of β-cells, a reduction of β-cell mass and insulin
content (Pinney et al., 2011; Frantz et al., 2012; Martin-Gronert
and Ozanne, 2012) and an increased susceptibility to insulin
resistance, visceral obesity, type 2 diabetes and other features of
the metabolic syndrome in adulthood (Hales and Barker, 1992;
Stocker et al., 2005; Sandovici et al., 2011). There are many
models used to study IUGR including maternal low protein diet
and placental insufficiency models (reviewed, Schwitzgebel et al.,
2009; Portha et al., 2011; Tarry-Adkins and Ozanne, 2011), in this
review we will focus on the model of maternal obesity.
In the United Kingdom around 50% of women of childbear-
ing age are either overweight with a body mass index (BMI) of
25–29.9 kg/m2 or obese (BMI ≥ 30 kg/m2) (Thangaratinam et al.,
2012). In 2010 5% of the UK maternity population were severely
obese (CMACE, 2010). Not only does increased adiposity affect
maternal health but there is also increasing evidence that obe-
sity during pregnancy and lactation can have long term effects on
the health of the child, increasing susceptibility to type 2 diabetes
(McCance et al., 1994; Nelson et al., 2010; Alfaradhi and Ozanne,
2011; Poston, 2012; Rkhzay-Jaf et al., 2012; Yang and Huffman,
2013).
Over the last decade evidence has grown that exposure of
rats to palatable and high-saturated-fat diets in-utero and/or
during lactation also compromises β-cell development and func-
tion in neonatal and weanling offspring (Cerf, 2011; Cerf et al.,
2012). A high fat diet (HFD) pre-gestation, during gestation or
postnatally will have different effects depending on the expo-
sure time to the diet (Dalgin and Prince, 2012). In the majority
of studies, HFD were administered to pregnant and/or lac-
tating rats to programme an adverse metabolic phenotype in
the offspring (Cerf, 2010). In neonates, exposure to a mater-
nal HFD throughout gestation was observed to have an adverse
effect on β-cell development which resulted in hyperglycemia
(Cerf et al., 2005). Similarly offspring of dams fed a HFD
through gestation alone showed altered neonatal islet mor-
phology with increased α-cell number and size and with an
opposite effect on the β-cell (Cerf et al., 2009). In contrast,
offspring of obese dams fed an obesogenic diet throughout
gestation and lactation were hyperinsulinemic at 3 months of
age (Samuelsson et al., 2008). This has been associated with
an increase in pancreatic insulin content, increased islet num-
ber and increased β-cell mass in early life (Rkhzay-Jaf et al.,
2011), which declines with age due to persistent stimulation
(Srinivasan et al., 2008). Similar observations were recorded in
sheep where, at lambing, reduced offspring β-cell numbers was
associated with an increase in β-cell apoptosis (Zhang et al.,
2011).
Previous studies conducted in the rat low-protein model of
IUGR, resulted in a reduction of PDX-1 protein expression (Park
et al., 2008) as well as a reduction in mRNA expression of
Glut2, Hnf4a, Pdx-1, Rfx6, and Ins (Pinney and Simmons, 2010;
Sandovici et al., 2011; Rodriguez-Trejo et al., 2012). Similarly,
exposure to a HFD can also alter both the glucose sensing and
insulin signaling mechanism of islets. Studies have shown that
offspring of obese over-nourished rat dams have a reduction in
insulin, glucokinase and GLUT2 protein expression (Kim et al.,
1995; Jorns et al., 2002; Cerf et al., 2006), as well as a reduc-
tion in PDX-1 protein (Reimer and Ahren, 2002; Cerf et al.,
2009). The alterations of these factors by gestational high fat
feeding may contribute to the reduction of β-cell number by
similar mechanisms to those seen in maternally undernourished
models.
While the mechanisms that govern the adaptation of the β-
cell to their altered in-utero environment are not fully understood
it is in part due to epigenetic modifications, including DNA
methylation, histone modifications and microRNAs, of which
DNA methylation is the most commonly studied. Methyl donors
are sourced from the diet and methylation patterns are estab-
lished during the early development of many organs including
the pancreas. Therefore, methyl donor imbalances could alter
these epigenetic patterns and increase an individual’s suscepti-
bility to metabolic disease in later life (Waterland and Garza,
2002; Sandovici et al., 2011). The many transcription factors that
control pancreatic development and endocrine cell fate may be
subjected to epigenetic regulation (Avrahami and Kaestner, 2012;
Sandovici et al., 2013). Previous studies of the developing pan-
creas have shown that epigenetic dysregulation brought about
by an altered in-utero environment increases the long term sus-
ceptibility to type 2 diabetes (Simmons, 2007; Thompson et al.,
2010). Park et al demonstrated that the development of type 2
diabetes following IUGR is in part due to epigenetic changes that
result in the silencing of Pdx-1 gene (Park et al., 2008). Due to
the commonalities in the phenotypes produced by the various
models of developmental programming (Portha et al., 2011), sim-
ilar abnormal metabolic intrauterine milieu such as a maternal
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HFDmay also affect the development of the fetus by permanently
modifying gene expression through epigenetic mechanisms.
More recently, a study in rodents has shown that a pater-
nal HFD results in impaired glucose tolerance in his female
offspring. By adulthood, these female offspring have impaired
β- cell function, associated with reduced islet area and the
altered expression of 642 pancreatic islet genes many of which
have been shown to be involved in calcium, MAPK- and
Wnt-signaling pathways, as well as apoptosis and the cell
cycle (Ng et al., 2010). Given the fact that maintaining dams
on a HFD for a single week during pregnancy can impair
β-cell development and function in the weanlings (Cerf et al.,
2007) and that a paternal HFD may affect offspring pancre-
atic islet development, the combined impact of both mater-
nal and paternal diet may produce an exacerbated or different
phenotype. Therefore, it is clearly important to understand
the potential impact of maternal and paternal obesity on the
offspring.
CONCLUSION
Recent studies in both animal models and in humans have
highlighted the impact of both increased maternal and paternal
obesity and over-nutrition on the in-utero and postnatal envi-
ronment and the consequences of developmental programming
on an infant’s susceptibility to metabolic disorders in later life.
It is therefore essential that we understand these programming
signals during the key developmental periods of organs such as
the pancreas. The identification and a greater understanding of
such programmingmechanisms will inform the design of success-
ful maternal intervention strategies, removing the risk of altered
organ development and rescue the offspring from developing a
detrimental phenotype in later life.
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